147 related articles for article (PubMed ID: 27463093)
1. Preoperative Chemotherapy and Metronomic Scheduling of Chemotherapy in Locally Advanced Oral Cancers.
Patil VM; Noronha V; Joshi A; Banavali SD; Muddu V; Prabhash K
Oncology; 2016; 91 Suppl 1():35-40. PubMed ID: 27463093
[TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy in technically unresectable locally advanced oral cavity cancers: does it make a difference?
Patil VM; Noronha V; Joshi A; Muddu VK; Gulia S; Bhosale B; Arya S; Juvekar S; Chatturvedi P; Chaukar DA; Pai P; D'cruz A; Prabhash K
Indian J Cancer; 2013; 50(1):1-8. PubMed ID: 23713035
[TBL] [Abstract][Full Text] [Related]
3. Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.
Noronha V; Patil V; Chaturvedi P; Mathrudev V; Menon N; Bhattacharjee A; Singh A; Peelay Z; Chakraborty S; Jadhav M; Alone M; Bhagyavant P; Kolkur M; Srinivas S; Das S; Roy S; Mandal T; Dsouza H; Saha S; Rai R; Srikanth A; Shah D; Khan A; Muthuluri H; Kumar A; Agarwal A; Rajpurohit A; Goli VB; Sekar A; Mantri A; Kanteti APK; Majumdar S; Khaddar S; Shenoy R; Elamarthi P; Rathnasamy N; Kashyap L; Abraham G; Booma N; Simha V; Chaukar D; Pai P; Nair S; Laskar S; Nawale K; Naidu P; Salian S; Shelar P; Raulo R; Dhumal SB; Prabhash K
Eur J Cancer; 2024 Mar; 200():113560. PubMed ID: 38306841
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy before surgery for unresectable head and neck cancer.
Schmaltz H; Borel C; Ciftci S; Takeda-Raguin C; Debry C; Schultz P; Dupret-Bories A
B-ENT; 2016; 12(1):29-32. PubMed ID: 27097391
[TBL] [Abstract][Full Text] [Related]
5. Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer center.
Patil VM; Chakraborty S; Shenoy PK; Manuprasad A; Sajith Babu TP; Shivkumar T; Babu S; Bhatterjee A; Balasubramanian S
Indian J Cancer; 2014; 51(1):69-72. PubMed ID: 24947100
[TBL] [Abstract][Full Text] [Related]
6. Oral metronomic scheduling of anticancer therapy-based treatment compared to existing standard of care in locally advanced oral squamous cell cancers: A matched-pair analysis.
Pai PS; Vaidya AD; Prabhash K; Banavali SD
Indian J Cancer; 2013; 50(2):135-41. PubMed ID: 23979205
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers.
Patil VM; Prabhash K; Noronha V; Joshi A; Muddu V; Dhumal S; Arya S; Juvekar S; Chaturvedi P; Chaukar D; Pai P; Kane S; Patil A; Agarwal JP; Ghosh-Lashkar S; Dcruz A
Oral Oncol; 2014 Oct; 50(10):1000-4. PubMed ID: 25130412
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
[TBL] [Abstract][Full Text] [Related]
9. Lack of survival advantage in patients with advanced, resectable squamous cell carcinoma of the oral cavity receiving induction chemotherapy with cisplatin (CDDP), docetaxel (TXT) and 5-fluorouracil (5FU).
Umeda M; Komatsubara H; Ojima Y; Minamikawa T; Shigeta T; Shibuya Y; Yokoo S; Komori T
Kobe J Med Sci; 2004; 50(5-6):189-96. PubMed ID: 16107776
[TBL] [Abstract][Full Text] [Related]
10. [Current role for induction chemotherapy in head and neck tumors].
Dietz A; Keilholz U; Werner J; Hagen R; Flentje M; Iro H
Laryngorhinootologie; 2008 Apr; 87(4):237-43; discussion 244. PubMed ID: 18365986
[TBL] [Abstract][Full Text] [Related]
11. Postoperative chemotherapy with cisplatin and 5-fluorouracil in cancer of the oral cavity and the oropharynx--long-term results.
Kovács AF; Ghahremani MT; Stefenelli U; Bitter K
J Chemother; 2003 Oct; 15(5):495-502. PubMed ID: 14598943
[TBL] [Abstract][Full Text] [Related]
12. Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.
Licitra L; Grandi C; Guzzo M; Mariani L; Lo Vullo S; Valvo F; Quattrone P; Valagussa P; Bonadonna G; Molinari R; Cantù G
J Clin Oncol; 2003 Jan; 21(2):327-33. PubMed ID: 12525526
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Chemotherapy in Technically Unresectable Oral Cancers: Does Human Papillomavirus Make a Difference?
Kane S; Patil VM; Joshi A; Noronha V; Muddu V; Dhumal S; Juvekar S; Arya S; D'Cruz A; Bhattacharjee A; Prabhash K
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):751-3. PubMed ID: 26412438
[No Abstract] [Full Text] [Related]
14. Is taxane/platinum/5 fluorouracil superior to taxane/platinum alone and does docetaxel trump paclitaxel in induction therapy for locally advanced oral cavity cancers?
Noronha V; Patil V; Joshi A; Muddu V; Bhattacharjee A; Juvekar S; Arya S; Chaturvedi P; Chaukar D; Pai PS; Dcruz AK; Prabhash K
Indian J Cancer; 2015; 52(1):70-3. PubMed ID: 26837979
[TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant radiochemotherapy for squamous cell carcinoma of the oral cavity].
Bootz F
HNO; 2008 Feb; 56(2):183-4. PubMed ID: 18231725
[No Abstract] [Full Text] [Related]
16. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
Kurita H; Koike T; Miyazawa H; Uehara S; Kobayashi H; Kurashina K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):915-21. PubMed ID: 16835480
[TBL] [Abstract][Full Text] [Related]
17. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
18. Metronomic chemotherapy in advanced oral cancers.
Patil V; Noronha V; D'cruz AK; Banavali SD; Prabhash K
J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S106-10. PubMed ID: 22322727
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival in locally advanced oral cavity cancer: an analysis of patients treated with neoadjuvant cisplatin-based chemotherapy followed by surgery.
Ruggeri EM; Carlini P; Pollera CF; De Marco S; Ruscito P; Pinnarò P; Nardi M; Giannarelli D; Cognetti F
Head Neck; 2005 Jun; 27(6):452-8. PubMed ID: 15880411
[TBL] [Abstract][Full Text] [Related]
20. Metronomic chemotherapy option for advanced oral cancer.
Gourd E
Lancet Oncol; 2019 Nov; 20(11):e614. PubMed ID: 31564522
[No Abstract] [Full Text] [Related]
[Next] [New Search]
